000303227 001__ 303227
000303227 005__ 20250731114306.0
000303227 0247_ $$2doi$$a10.3390/cancers17142362
000303227 0247_ $$2pmid$$apmid:40723294
000303227 037__ $$aDKFZ-2025-01578
000303227 041__ $$aEnglish
000303227 082__ $$a610
000303227 1001_ $$0P:(DE-He78)3ac0bc7cf0e8ab1e1bc05c7889bfa3df$$aJarahian, Mostafa$$b0$$eFirst author
000303227 245__ $$aCorrection: Jarahian et al. Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape. Cancers 2021, 13, 5203.
000303227 260__ $$aBasel$$bMDPI$$c2025
000303227 3367_ $$2DRIVER$$aarticle
000303227 3367_ $$2DataCite$$aOutput Types/Journal article
000303227 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753941519_19397$$xErratum/Correction
000303227 3367_ $$2BibTeX$$aARTICLE
000303227 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303227 3367_ $$00$$2EndNote$$aJournal Article
000303227 500__ $$a#EA:G401#LA:G401#
000303227 520__ $$aThere was an error in the original publication [...].
000303227 536__ $$0G:(DE-HGF)POF4-319H$$a319H - Addenda (POF4-319H)$$cPOF4-319H$$fPOF IV$$x0
000303227 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303227 7001_ $$aMarofi, Faroogh$$b1
000303227 7001_ $$aMaashi, Marwah Suliman$$b2
000303227 7001_ $$aGhaebi, Mahnaz$$b3
000303227 7001_ $$00000-0003-1061-8229$$aKhezri, Abdolrahman$$b4
000303227 7001_ $$0P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676$$aBerger, Martin$$b5$$eLast author
000303227 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers17142362$$gVol. 17, no. 14, p. 2362 -$$n14$$p2362$$tCancers$$v17$$x2072-6694$$y2025
000303227 909CO $$ooai:inrepo02.dkfz.de:303227$$pVDB
000303227 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3ac0bc7cf0e8ab1e1bc05c7889bfa3df$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000303227 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000303227 9131_ $$0G:(DE-HGF)POF4-319H$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vAddenda$$x0
000303227 9141_ $$y2025
000303227 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2022$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-14
000303227 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2022$$d2024-12-14
000303227 9202_ $$0I:(DE-He78)G401-20160331$$kG401$$lMolekulare Toxikologie und Chemotherapie$$x0
000303227 9200_ $$0I:(DE-He78)G401-20160331$$kG401$$lMolekulare Toxikologie und Chemotherapie$$x0
000303227 9201_ $$0I:(DE-He78)G401-20160331$$kG401$$lMolekulare Toxikologie und Chemotherapie$$x0
000303227 980__ $$ajournal
000303227 980__ $$aVDB
000303227 980__ $$aI:(DE-He78)G401-20160331
000303227 980__ $$aUNRESTRICTED